ASCO25: Amgen’s Nplate proves effective in GI cancer-linked thrombocytopaenia

Nplate improved platelet response and reduced therapy modification for patients with chemotherapy-induced thrombocytopaenia.

Jun 3, 2025 - 06:00
ASCO25: Amgen’s Nplate proves effective in GI cancer-linked thrombocytopaenia
Nplate improved platelet response and reduced therapy modification for patients with chemotherapy-induced thrombocytopaenia.

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow